{{Rsnum
|rsid=2255235
|Gene=B2M
|Chromosome=15
|position=44711166
|Orientation=plus
|GMAF=0.1657
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=B2M
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 77.0 | 22.1 | 0.9
| HCB | 74.5 | 22.6 | 2.9
| JPT | 86.6 | 12.5 | 0.9
| YRI | 40.8 | 49.0 | 10.2
| ASW | 42.1 | 49.1 | 8.8
| CHB | 74.5 | 22.6 | 2.9
| CHD | 76.1 | 23.9 | 0.0
| GIH | 63.4 | 32.7 | 4.0
| LWK | 42.7 | 45.5 | 11.8
| MEX | 72.4 | 25.9 | 1.7
| MKK | 42.9 | 43.6 | 13.5
| TSI | 82.4 | 17.6 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21659360
|Title=Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}